Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Administration of Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Analgesia in Posterior Lumbar Spine Surgery - A Prospective Randomized Study

NCT03514277 is registered in ClinicalTrials.gov with Virtua Health, Inc. as lead sponsor.

NCT NCT03514277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03514277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Administration of Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Analgesia in Posterior Lumbar Spine Surgery - A Prospective Randomized Study
Lead sponsor
Virtua Health, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
December 1, 2016
Completion date
December 31, 2019
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deformity of spine, low back pain, lumbar disc degeneration, lumbar disc herniation, lumbosacral radiculopathy, spondylolisthesis, spondylolysis, stenosis